AbbVie Resolves HUMIRA® (adalimumab) U.S. Litigation with Alvotech

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. KLAR
3. HD
4. AMLX
5. SPY
6. DOO
7. METC
8. ARGX
9. SNOW
10. INFQ

Go back to AbbVie Resolves HUMIRA® (adalimumab) U.S. Litigation with Alvotech
AbbVie (NYSE: ABBV) Delayed: 258.92 --0 (-0%)
Previous Close $258.92    52 Week High $68.12 
Open $258.92    52 Week Low $50.71 
Day High $258.92    P/E 56.16 
Day Low $258.92    EPS $4.61 
Volume 1,680